アミロイドーシス(Amyloidosis):グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Amyloidosis Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Amyloidosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Amyloidosis to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Amyloidosis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Amyloidosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Amyloidosis 33
Jan 09, 2014: BELLUS Health provides update on KIACTA Phase III orphan drug study 33
Dec 24, 2013: Widely-used anti-inflammatory drug shows success in treatment of amyloidosis 33
Dec 16, 2013: Alnylam Initiates Phase II Clinical Trial with ALN-TTRsc, a Subcutaneously Delivered RNAi Therapeutic Targeting Transthyretin in Development for the Treatment of TTR-Mediated Amyloidosis 34
Nov 10, 2013: Alnylam Reports Positive Phase II Data for Patisiran, an RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis, and Initiates Phase III Trial 35
Sep 30, 2013: Alnylam Completes Enrollment of Phase II Clinical Trial and Initiates Open-Label Extension (OLE) Study with ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidos 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Alnylam Pharmaceuticals, Inc. 40
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Takeda Pharmaceutical Company Limited 43
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43
Isis Pharmaceuticals, Inc. 44
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 44
Prothena Corporation plc 45
Clinical Trial Overview of Prothena Corporation plc 45
Bellus Health Inc. 46
Clinical Trial Overview of Bellus Health Inc. 46
C.T. Development America, Inc. 47
Clinical Trial Overview of C.T. Development America, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Boston Medical Center 48
Clinical Trial Overview of Boston Medical Center 48
Mayo Clinic 49
Clinical Trial Overview of Mayo Clinic 49
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Stanford University 51
Clinical Trial Overview of Stanford University 51
Boston University 52
Clinical Trial Overview of Boston University 52
IRCCS Policlinico San Matteo 53
Clinical Trial Overview of IRCCS Policlinico San Matteo 53
IRCCS Policlinico S. Donato 54
Clinical Trial Overview of IRCCS Policlinico S. Donato 54
Memorial Sloan Kettering Cancer Center 55
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 55
Umea University 56
Clinical Trial Overview of Umea University 56
Southwest Oncology Group 57
Clinical Trial Overview of Southwest Oncology Group 57
Five Key Clinical Profiles 58
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 110


【レポート販売概要】

■ タイトル:アミロイドーシス(Amyloidosis):グローバル臨床試験レビュー(2014年上半期)
■ 英文:Amyloidosis Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月5日
■ 調査会社:GlobalData
■ 商品コード:GDHC2131CTIDB
■ 調査対象地域:グローバル
  • ヨーロッパのIndustrial Tall Oil Fatty Acids市場
    Industrial Tall Oil Fatty Acids: European Union Market Outlook 2012 and Forecast till 2017 provides a complete overview of the market condition. All available data is presented in a comprehensive and easily accessed format. The report provides our Clients with a clear understanding of market current state and future development. Scope The report contains an in-depth analysis of the European Union …
  • パーソナルケア製品用成分の世界市場:界面活性剤、コンディショニング・ポリマー、皮膚軟化剤、レオロジー改質剤
    The personal care ingredients market is projected to register a CAGR of 5.4% between 2015 and 2020 to reach $17,600.0 million. The market for personal care ingredients is estimated to grow on account of changing lifestyle and increase in spending capacity. Huge demand from Asia-Pacific region and increasing demand for multi-functional ingredients are also major driving factors driving the personal …
  • 世界の商用ヘリコプタ市場動向2013-2023:主な開発プロジェクト
    This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Commercial Helicopter. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
  • ゴミ圧縮機の世界市場2016-2020
    About Trash Compactor Trash compactors have primarily found acceptance in North America owing to the averseness of Americans to pay for garbage disposable by private contractors. The market has witnessed the evolution of trash compactors and modern models feature advancements in terms of cleanliness and odor removal. Modern trash compactors are coated with antimicrobials to inhibit the growth of o …
  • Remicade(クローン病治療薬):市場予測及び分析(~2022)
    Remicade (Crohn’s Disease) - Forecast and Market Analysis to 2022 Summary The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety a …
  • 臨床試験電子化ソリューション(eClinical)の世界市場予測(~2022年)
    The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising …
  • 世界の自動車軽量素材市場調査:Global Automotive Lightweight Materials Market 2014-2018
    TechNavio's analysts forecast the Global Automotive Lightweight Materials market to grow at a CAGR of 14.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the stringent laws and regulations pertaining to the environment. The Global Automotive Lightweight Materials market has also been witnessing the increasing use of high-strength plastics. However, …
  • 世界の髄核置換装置市場:医療機器パイプライン分析2016
    Nucleus Replacement - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview of Nucleus Replacement currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development …
  • アルツハイマー型認知症:グローバル臨床試験レビュー(2014年上半期)
    Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Dementia Associated With Alzheimer’s Disease Global Clinical Trials Review, H1, 2014" provides data on the Dementia Associated With Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dement …
  • 生体吸収性スキャフォールドの世界市場分析および予測
    MediPoint: Bioabsorbable Scaffolds - Global Analysis and Market Forecasts Summary Coronary artery disease (CAD) and peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to permanent drug-eluting stents (DES) and bare metal stent …
  • 企業向け通信インフラの世界市場2016-2020
    About the Enterprise Communication Infrastructure Market Companies across the world are adopting advanced programs and integration solutions to keep their businesses running smoothly in a competitive environment. Enterprises started integrating communication tools such as text messaging, video conferencing, voice messaging, and mobility features to enhance their communication technology and improv …
  • マイクロカプセル化成分のアジア太平洋市場:色素、ビタミン、UVフィルター、美白成分、有効成分、エッセンシャルオイル、老化防止成分
    Microencapsulation is a process in which ingredients such as pigments, vitamins, UV filters, and others, are encapsulated to form a capsule. The Asia-Pacific microencapsulated ingredients market was valued at $120.59 million in 2018 and is estimated to reach $193.36 million by 2026, growing at a CAGR of 6.0% from 2019 to 2026. Microencapsulation is used increasingly in the skin care and personal c …
  • バイオポリマーの世界市場2017-2021
    About Biopolymers Polymers, which are petrochemical derivatives, account for about 80% of the total polymeric materials globally produced. Polymer production has been a cause of concern to nations worldwide. The dependency on the petrochemical industry had been irreplaceable until the discovery of biopolymers two decades ago. The emergence of biopolymers is seen as a step toward sustainable develo …
  • 世界の耐火試験市場:サービス種類別(テスト、検査、認証)、ソーシング種類別(社内、外部委託)、用途別(消費財&小売、化学、建設&インフラ、鉱業)、地域別
    “Fire testing market projected to grow at a CAGR of 6.4% from 2019 to 2024” The global fire testing market is expected to grow from USD 6.3 billion in 2019 to USD 8.6 billion by 2024, at a CAGR of 6.4% during the forecast period. The fire testing market is growing, owing to an increase in demand for TIC services for applications such as automotive, construction and infrastructure, consumer goods, …
  • 癌診断用の画像装置:グローバル市場分析と予測
    MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundatio …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。